Midkine as a factor to counteract the deposition of amyloid -peptide plaques: In vitro analysis and examination in knockout mice

International Archives of Medicine

Volumn 4, Issue 1, 2011, Pages

  Muramatsul, Hisako ^a,b   Yokoi, Katsunori ^a   Chen, Lan ^a   Ichihara Tanaka, Keiko ^a,b   Kimura, Terutoshi ^c   Muramatsu, Takashi ^a,b  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

^c Peptide Institute Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; HEPARIN; MIDKINE; PLEIOTROPHIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CARBOXY TERMINAL SEQUENCE; CELL ASSAY; CELL MIGRATION; CONTROLLED STUDY; HIPPOCAMPUS; IN VITRO STUDY; MICROGLIA; MOUSE; NONHUMAN; PLAQUE FORMING CELL; PROTEIN BINDING; PROTEIN FUNCTION; SURFACE PLASMON RESONANCE;

EID: 78651229012     PISSN: None     EISSN: 17557682     Source Type: Journal    
DOI: 10.1186/1755-7682-4-1     Document Type: Article

References (44)

1. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. J Hardy DJ Selkoe, Science 2002 297 353 356 10.1126/science.1072994 12130773
2. Therapeutic strategies for Alzheimer's disease. MS Wolfe, Nat Rev Drug Discov 2002 1 859 866 10.1038/nrd938 12415246
3. Immunology and immunotherapy of Alzheimer's disease. HL Weiner D Frenkel, Nat Rev Immunol 2006 6 404 416 10.1038/nri1843 16639431
4. The immune system, amyloid- peptide, and Alzheimer's disease. ME Weksler G Gouras NR Relkin P Szabo, Immunol Rev 2005 205 244 256 10.1111/j.0105-2896. 2005.00264.x 15882358
5. Immunotherapy for Alzheimer's disease. DS Gelinas K DaSilva D Fenili P St George-Hyslop J McLaurin, Proc Natl Acad Sci USA 2004 101 Suppl 2 14657 14662 10.1073/pnas.0404866101 15297619
6. Anti-amiloid - immunotherapy in Alzheimer's disease: relevance of transgenic mouse models to clinical trials. DM Wilcock CA Colton, J Alzheimers Dis 2008 15 555 569 19096156
7. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. T Muramatsu, J Biochem 2002 132 359 371 12204104
8. Midkine and pleiotrophin in neural development and cancer. K Kadomatsu T Muramatsu, Cancer Lett 2004 204 127 143 10.1016/S0304-3835(03)00450-6 15013213
9. Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases. T Muramatsu, Proc Japan Acad Ser B 2010 86 410 425 10.2183/pjab.86.410
10. Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. H Muramatsu H Shirahama S Yonezawa H Maruta T Muramatsu, Dev Biol 1993 159 392 402 10.1006/dbio.1993.1250 8405666
11. Retinoic acid responsive gene product, midkine, has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture. M Michikawa S Kikuchi H Muramatsu T Muramatsu SU Kim, J Neurosci Res 1993 35 530 539 10.1002/jnr.490350509 8377224
12. Midkine inhibits caspase-dependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. K Owada N Sanjo T Kobayashi H Mizusawa H Muramatsu T Muramatsu M Michikawa, J Neurochem 1999 73 2084 2092 10537068
13. Intraventricular administration of the neurotrophic factor midkine ameliorates hippocampal delayed neuronal death following transient forebrain ischemia in gerbils. Y Yoshida S Ikematsu T Moritoyo M Goto J Tsutsui S Sakuma M Osame T Muramatsu, Brain Res 2001 894 46 55 10.1016/S0006-8993(00)03209-1 11245814
14. Neointima formation in a restenosis model is suppressed in midkine-deficient mice. M Horiba K Kadomatsu E Nakamura H Muramatsu S Ikematsu S Sakuma K Hayashi Y Yuzawa S Matsuo M Kuzuya T Kaname M Hirai H Saito T Muramatsu, J Clin Invest 2000 105 489 495 10.1172/JCI7208 10683378
15. Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury. W Sato K Kadomatsu Y Yuzawa H Muramatsu N Hotta S Matsuo T Muramatsu, J Immunol 2001 167 3463 3469 11544339
16. A receptor-like protein-tyrosine phosphatase PTP/RPTP binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTP N Maeda K Ichihara-Tanaka T Kimura K Kadomatsu T Muramatsu M Noda, J Biol Chem 1999 274 12474 12479 10.1074/jbc.274.18.12474 10212223
17. Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells. Y Takei K Kadomatsu S Matsuo H Itoh K Nakazawa S Kubota T Muramatsu, Cancer Res 2001 61 8486 8491 11731432
18. Lack of the growth factor midkine enhances survival against cisplatin-induced renal damage. H Kawai W Sato Y Yuzawa T Kosugi S Matsuo Y Takei K Kadomatsu T Muramatsu, Am J Pathol 2004 165 1603 1612 15509530
19. Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis. K Maruyama H Muramatsu N Ishiguro T Muramatsu, Arthritis Rheum 2004 50 1420 1429 10.1002/art.20175 15146411
20. Inhibition of midkine alleviates experimental autoimmune encephalomyelitis through the expansion of regulatory T cell population. J Wang H Takeuchi Y Sonobe S Jin T Mizuno S Miyakawa M Fujiwara Y Nakamura T Kato H Muramatsu T Muramatsu A Suzumura, Proc Natl Acad Sci USA 2008 105 3915 3920 10.1073/pnas.0709592105 18319343
21. Midkine plays a protective role against cardiac ischemia/reperfusion injury through a reduction of apoptotic reaction. M Horiba K Kadomatsu K Yasui JK Lee H Takenaka A Sumida K Kamiya S Chen S Sakuma T Muramatsu I Kodama, Circulation 2006 114 1713 1720 10.1161/CIRCULATIONAHA.106.632273 17015789
22. Midkine, a novel neurotrophic factor, is present in senile plaques of Alzheimer disease. O Yasuhara H Muramatsu SU Kim T Muramatsu H Maruta PL McGeer, Biochem Biophys Res Commun 1993 192 246 251 10.1006/bbrc.1993.1406 8476427
23. Increased midkine levels in sera from patients with Alzheimer's disease. RH Salama H Muramatsu E Shimizu K Hashimoto S Ohgake H Watanabe N Komatsu N Okamura K Koike N Shinoda S Okada M Iyo T Muramatsu, Prog Neuropsychopharmacol Biol Psychiatry 2005 29 611 616 10.1016/j.pnpbp.2005.01.018 15866365
24. Inhibition of -amyloid cytotoxicity by midkine. GS Yu J Hu H Nakagawa, Neurosci Lett 1998 254 125 128 10.1016/S0304-3940(98)00685-5 10214973
25. Inhibition of A fibril formation and A-induced cytotoxicity by senile plaque-associated proteins. A Monji I Yoshida K Tashiro Y Hayashi K Matsuda N Tashiro, Neurosci Lett 2000 278 81 84 10.1016/S0304-3940(99)00899-X 10643806
26. Pleiotrophin induces expression of inflammatory cytokines in peripheral blood mononuclear cells. A Achour JP M'bika F Baudouin D Caruelle J Courty, Biochimie 2008 90 1791 1795 10.1016/j.biochi.2008.04.010 18486628
27. Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. TF Deuel N Zhang HJ Yeh I Silos-Santiago ZY Wang, Arch Biochem Biophys 2002 397 162 167 10.1006/abbi.2001.2705 11795867
28. HB-GAM (heparin-binding growth-associated molecule) and heparin-type glycans in the development and placiticity of neuron-target contacts. H Rauvala HB Peng, Prog Neurobiol 1997 52 127 144 10.1016/S0301-0082(97)00007-5 9185236
29. HB-GAM is a cytokine present in Alzheimer's and Down's syndrome Lesions. T Wisniewski M Lalowski M Baumann H Rauvala E Raulo R Nolo B Frangione, Neuroreport 1996 7 667 671 10.1097/00001756-199601310-00068 8730853
30. Solution synthesis of human midkine, a novel heparin-binding neurotrophic factor consisiting of 121 amino acid residues with five disulphide bonds. T Inui J Bodi S Kubo H Nishio T Kimura S Kojima H Maruta T Muramatsu S Sakakibara, J Peptide Sci 1996 2 28 39
31. Solution synthesis and biological activity of human pleiotrophin, a novel heparin-binding neurotrophic factor consisting of 136 amino acid residues with five disulfide bonds. T Inui M Nakao H Nishio Y Nishiuchi S Kojima T Muramatu T Kimura, J Peptide Res 2000 55 384 397 10.1034/j.1399-3011.2000.00703.x (Pubitemid 30324174)
32. Identification of heparin-binding sites in midkine and their role in neurite-promotion. T Asai K Watanabe K Ichihara-Tanaka N Kaneda S Kojima A Iguchi F Inagaki T Muramatsu, Biochem Biophys Res Commun 1997 236 66 70 10.1006/bbrc.1997.6905 9223427
33. Female infertility in mice deficient in midkine and pleiotrophin, which form a distinct family of growth factors. H Muramatsu P Zou N Kurosawa K Ichihara-Tanaka K Maruyama K Inoh T Sakai L Chen M Sato T Muramatsu, Genes Cells 2006 11 1405 1417 10.1111/j.1365-2443.2006.01028.x 17121547
34. Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behaviour. E Nakamura K Kadomatsu S Yuasa H Muramatsu T Mamiya T Nabeshima QW Fan K Ishiguro T Igakura S Matsubara T Kaname M Horiba H Saito T Muramatsu, Genes Cells 1998 3 811 822 10.1046/j.1365-2443.1998.00231.x 10096022
35. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon. A Suzumura SGE Mezitis NK Gonatus DH Silberberg, J Neuroimmunol 1987 15 263 278 10.1016/0165-5728(87)90121-4 3110208
36. Solution structure of midkine, a new heparin-binding growth factor. W Iwasaki K Nagata H Hatanaka T Inui T Kimura T Muramatsu K Yoshida M Tasumi F Inagaki, EMBO J 1997 16 6936 6946 10.1093/emboj/16.23.6936 9384573
37. The role of the immune system in clearance of A from the brain. D Boche JA Nicoll, Brain Pathol 2008 18 267 278 10.1111/j.1750-3639.2008.00134.x 18363937
38. Localization of heparin-binding, neurite outgrowth and antigenic regions in midkine molecule. H Muramatsu T Inui T Kimura S Sakakibara XJ Song H Maruta T Muramatsu, Biochem Biophys Res Commun 1994 203 1131 1139 10.1006/bbrc.1994.2300 8093031
39. Interactions of Alzheimer amyloid- peptides with glycosaminoglycans effects on fibril nucleation and growth. J McLaurin T Franklin X Zhang J Deng PE Fraser, Eur J Biochem 1999 266 1101 1110 10.1046/j.1432-1327.1999.00957.x 10583407
40. The two thrombospondin type I repeat domains of the heparin-binding growth-associated molecule bind to heparin/heparan sulfate and regulate neurite extension and plasticity in hippocampal neurons. E Raulo S Tumova I Pavlov M Pekkanen A Hienola E Klankki N Kalkkinen T Taira I Kilpelainen H Rauvala, J Biol Chem 2005 280 41576 41583 10.1074/jbc.M506457200 16155004
41. Enzyme-linked immunoassay for midkine and its application to evaluation of midkine levels in developing mouse brains and sera from patients with hepatocellular carcinomas. H Muramatsu X Song N Koide H Hada T Tsuji K Kadomatsu T Inui T Kimura S Sakakibara T Muramatsu, J Biochem 1996 119 1171 1175 8827454
42. Neuronal cell adhesion mediated by the heparin-binding neuroregulatory factor, midkine, is specifically inhibited by chondroitin sulfate E. Structural and functional implication of the oversulfated chondroitin sulfate. C Ueoka N Kaneda I Okazaki S Nadanaka T Muramatsu K Sugahara, J Biol Chem 2000 275 37407 37413 10.1074/jbc.M002538200 10978312
43. Manipulation of microglial activation as a therapeutic strategy in Alzheimer's disease. FS Shie RL Woltjer, Curr Med Chem 2007 14 2865 2871 10.2174/092986707782359981 18045132
44. Wojtera M. Sikorska B. Sobow T. Liberski P.P., Microglial cells in neurodegenerative disorders, Folia Neuropathol, 2005, 43, 311-321, 16416395.